Bothell, WA, United States of America

Alder Biopharmaceuticals, Inc.

USPTO Granted Patents = 8



Trademarks = 1

Forward Citations = 99

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal John A Latham (7 out of 125 patents)

silverMedal Daniel S Allison (4 out of 34 patents)

bronzeMedal Ilya I Tolstorukov (4 out of 10 patents)

4.  James M Cregg (4 out of 29 patents)

5.  Leon F Garcia-Martinez (4 out of 89 patents)

6.  Ethan Wayne Ojala (4 out of 65 patents)

7.  Benjamin H Dutzar (3 out of 72 patents)

8.  Pei Fan (3 out of 34 patents)

9.  Charlie Karasek (3 out of 25 patents)

10.  Jenny Mulligan (3 out of 25 patents)

11.  Michelle Scalley-Kim (3 out of 27 patents)

12.  Jeffrey T L Smith (3 out of 95 patents)

13.  Mark Litton (3 out of 20 patents)

14.  Erica Ann Stewart (3 out of 30 patents)

15.  Andrew Lawrence Feldhaus (2 out of 28 patents)


8 patents:

Company Overview
Alder Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutic antibodies for the treatment of migraine. Their lead product candidate, eptinezumab, is in late-stage clinical development for the prevention of migraines.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#56 in Bothell, WA

#826 in Washington

#35,941 in US

Bothell, WA (US)
Bothell, WA, United States of America
Forward Citations = 99

28 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alder Biopharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/alder-biopharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…